| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0B | $8.6B | $7.4B | $5.5B | $5.2B | $1.4B | $1.4B | $1.4B |
| Cost of Revenue | $5.6B | $5.3B | $4.6B | $3.4B | $3.2B | $3.0B | $3.2B | $3.2B |
| Gross Profit | $3.5B | $3.2B | $2.7B | $2.1B | $2.0B | $0.5B | $0.5B | $0.5B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $1.9B | $1.9B | $1.8B | $1.2B | $1.2B | $1.1B | $1.2B | $1.2B |
| Operating Income | $1.2B | $1.0B | $0.7B | $0.6B | $0.6B | $0.2B | $0.2B | $0.2B |
| Net Income | $1.0B | $0.9B | $0.6B | $0.4B | $0.4B | $0.1B | $0.1B | $0.2B |
| EPS (Basic) | $3.93 | $3.67 | $2.81 | $1.97 | $2.37 | $0.82 | $0.66 | $1.25 |
| EPS (Diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 | $0.82 | $0.65 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.6B | $16.5B | $16.1B | $8.0B | $8.3B | $8.8B | $7.7B | $7.2B |
| Current Assets | $4.6B | $4.1B | $3.9B | $3.0B | $3.2B | $3.5B | $2.5B | $2.1B |
| Cash & Equivalents | $1.5B | $1.1B | $1.0B | $0.9B | $1.3B | $1.9B | $0.7B | $0.3B |
| Total Liabilities | $5.9B | $5.6B | $5.9B | $4.4B | $5.0B | $5.8B | $4.7B | $4.4B |
| Current Liabilities | $2.9B | $2.3B | $2.2B | $1.6B | $1.4B | $2.0B | $1.5B | $1.4B |
| Stockholders' Equity | $11.5B | $10.6B | $10.2B | $3.5B | $3.2B | $3.0B | $3.0B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.3B | $0.8B | $0.6B | $0.5B | $0.8B | $0.8B | $0.6B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.6B | $-0.2B | $-0.2B | $-0.2B | $-0.2B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-0.6B | $-0.2B | $-0.8B | $-0.9B | $0.5B | $-0.2B | $-0.0B |